Nasdaq · CIK 0001766400
PNTG Pennant Group, Inc.
Insider trading from SEC Form 4. Last filing Apr 17, 2026. Close $39.73 on Oct 9, 2026, +68% from the 52-week low and -6% from the high.
Pennant Group, Inc. (PNTG) has 54 SEC Form 4 filings on file from 13 insiders, the latest filed on Apr 17, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
5 open-market trades have been scored at PNTG. The newest: Kirk Sterling Cheney (EVP, GC and Corp Secy) sold $21k of stock on Jul 28, 2025, filed Aug 7, 2025, scored 3 (weak), under a 10b5-1 plan. The largest of the 5 shown: JoAnne Stringfield (director) sold $147k on May 20, 2025, scored 16 (weak). 2 insiders sold within 14 days of each other around Jul 28, 2025.
PNTG closed at $39.73 on Oct 9, 2026, 68% above its 52-week low and 6% below its 52-week high.
6 Form 144 notices of planned sales are on file, the latest filed Jul 28, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Pennant Group, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 3Weak | Kirk Sterling Cheney EVP, GC and Corp Secy sell | $21k 880 shares | -6% | +5% from low-37% from high | |
| 23Weak | Brent Guerisoli Chief Executive Officer sell | $93k 3,995 shares | -5% | +5% from low-37% from high | |
| 16Weak | JoAnne Stringfield director sell | $147k 5,000 shares | -14% | +33% from low-20% from high | |
| 0Weak | JoAnne Stringfield director sell | $17k 665 shares | -2% | +14% from low-31% from high | |
| 0Weak | JoAnne Stringfield director sell | $13k 380 shares | -1% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 28, 2025 | Guerisoli Brent Officer, Director | 3,995 0.01% of outstanding | $93k | Jul 28, 2025 | none |
| Jul 28, 2025 | Guerisoli Brent Officer, Director | 3,995 0.01% of outstanding | $93k | Jul 28, 2025 | none |
| May 20, 2025 | Stringfield JoAnne Director | 11,954 0.03% of outstanding | $352k | May 20, 2025 | $17k |
| May 1, 2025 | Stringfield JoAnne Director | 665 0.00% of outstanding | $17k | May 1, 2025 | none |
| Jan 30, 2025 | Stringfield JoAnne Director | 665 0.00% of outstanding | $19k | Jan 30, 2025 | none |
| Oct 23, 2024 | Stringfield JoAnne Director | 380 0.00% of outstanding | $13k | Oct 23, 2024 | $11k |
Transactions
The newest 50 of 63 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Christopher R. Christensen director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 144,091 | Apr 17, 2026 |
| Apr 15, 2026 | Stephen M R Covey director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 42,150 | Apr 17, 2026 |
| Mar 5, 2026 | Jason Paul Steik Chief Clinical Officer | AGrant or award Stock Option (right to buy)derivative | +26,000 | $33.30 | $866k | 26,000 | Mar 12, 2026 |
| Mar 3, 2026 | Brent Guerisoli Chief Executive Officer | AGrant or award Common Stock | +20,052 | $0.00 | $0 | 102,030 | Mar 12, 2026 |
| Mar 3, 2026 | Lynette Walbom Chief Financial Officer | AGrant or award Common Stock | +14,292 | $0.00 | $0 | 16,955 | Mar 12, 2026 |
| Mar 3, 2026 | John J Gochnour Chief Operating Officer | AGrant or award Common Stock | +18,565 | $0.00 | $0 | 152,815 | Mar 12, 2026 |
| Mar 3, 2026 | Kirk Sterling Cheney EVP, GC and Corp Secy | AGrant or award Common Stock | +4,085 | $0.00 | $0 | 21,005 | Mar 12, 2026 |
| Mar 5, 2026 | John J Gochnour Chief Operating Officer | AGrant or award Stock Option (right to buy)derivative | +41,000 | $33.30 | $1.4M | 41,000 | Mar 12, 2026 |
| Mar 5, 2026 | Brent Guerisoli Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +45,000 | $33.30 | $1.5M | 45,000 | Mar 12, 2026 |
| Mar 5, 2026 | Kirk Sterling Cheney EVP, GC and Corp Secy | AGrant or award Stock Option (right to buy)derivative | +30,000 | $33.30 | $999k | 30,000 | Mar 12, 2026 |
| Mar 5, 2026 | Lynette Walbom Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +34,000 | $33.30 | $1.1M | 34,000 | Mar 12, 2026 |
| Jan 15, 2026 | John G. Nackel director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 170,765 | Jan 21, 2026 |
| Jan 15, 2026 | Barry M Smith director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 98,699 | Jan 21, 2026 |
| Jan 15, 2026 | Suzanne D. Snapper director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 226,564 | Jan 21, 2026 |
| Jan 15, 2026 | Stephen M R Covey director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 40,250 | Jan 21, 2026 |
| Jan 15, 2026 | Christopher R. Christensen director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 142,191 | Jan 21, 2026 |
| Jan 15, 2026 | Scott E Lamb director | AGrant or award Common Stock | +2,400 | $0.00 | $0 | 54,135 | Jan 21, 2026 |
| Jan 15, 2026 | Gregory K Morris Sr. director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 33,500 | Jan 21, 2026 |
| Nov 11, 2025 | Kirk Sterling Cheney EVP, GC and Corp Secy | MOption exercise Common Stock | +3,800 | $15.09 | $57k | 16,920 | Nov 13, 2025 |
| Nov 11, 2025 | Kirk Sterling Cheney EVP, GC and Corp Secy | MOption exercise Stock Option (right to buy)derivative | -3,800 | - | - | 4,200 | Nov 13, 2025 |
| Oct 15, 2025 | Stephen M R Covey director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 38,350 | Oct 16, 2025 |
| Oct 15, 2025 | Christopher R. Christensen director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 140,291 | Oct 16, 2025 |
| Oct 15, 2025 | Scott E Lamb director | AGrant or award Common Stock | +2,400 | $0.00 | $0 | 51,735 | Oct 16, 2025 |
| Oct 15, 2025 | Gregory K Morris Sr. director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 31,600 | Oct 16, 2025 |
| Oct 15, 2025 | John G. Nackel director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 168,865 | Oct 16, 2025 |
| Oct 15, 2025 | Suzanne D. Snapper director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 224,664 | Oct 16, 2025 |
| Oct 15, 2025 | Barry M Smith director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 96,799 | Oct 16, 2025 |
| Oct 9, 2025 | Barry M Smith director | MOption exercise Common Stock | +10,000 | $11.35 | $114k | 94,899 | Oct 14, 2025 |
| Oct 9, 2025 | Barry M Smith director | MOption exercise Stock Option (right to buy)derivative | -10,000 | - | - | 10,000 | Oct 14, 2025 |
| Jul 28, 2025 | Kirk Sterling Cheney EVP, GC and Corp Secy | SOpen-market sale Common Stock10b5-1 | -880 | $23.34 | $21k | 13,120 | Aug 7, 2025 |
| Jul 28, 2025 | Brent Guerisoli Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -3,995 | $23.34 | $93k | 81,978 | Jul 31, 2025 |
| Jul 15, 2025 | Stephen M R Covey director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 36,450 | Jul 17, 2025 |
| Jul 15, 2025 | Christopher R. Christensen director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 138,391 | Jul 17, 2025 |
| Jul 15, 2025 | Scott E Lamb director | AGrant or award Common Stock | +2,400 | $0.00 | $0 | 49,335 | Jul 17, 2025 |
| Jul 15, 2025 | Gregory K Morris Sr. director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 29,700 | Jul 17, 2025 |
| Jul 15, 2025 | John G. Nackel director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 166,965 | Jul 17, 2025 |
| Jul 15, 2025 | Barry M Smith director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 84,899 | Jul 17, 2025 |
| Jul 15, 2025 | Suzanne D. Snapper director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 222,764 | Jul 17, 2025 |
| May 20, 2025 | JoAnne Stringfield director | MOption exercise Common Stock | +5,000 | $15.09 | $75k | 35,275 | May 23, 2025 |
| May 20, 2025 | JoAnne Stringfield director | SOpen-market sale Common Stock | -5,000 | $29.47 | $147k | 30,275 | May 23, 2025 |
| May 20, 2025 | JoAnne Stringfield director | MOption exercise Stock Option (right to buy)derivative | -5,000 | $29.47 | $147k | 0 | May 23, 2025 |
| May 1, 2025 | JoAnne Stringfield director | SOpen-market sale Common Stock10b5-1 | -665 | $25.62 | $17k | 30,275 | May 5, 2025 |
| Apr 29, 2025 | John J Gochnour Chief Operating Officer | MOption exercise Common Stock | +6,286 | $7.42 | $47k | 134,250 | May 1, 2025 |
| Apr 29, 2025 | John J Gochnour Chief Operating Officer | MOption exercise Stock Option (right to buy)derivative | -6,286 | $7.42 | $47k | 0 | May 1, 2025 |
| Apr 15, 2025 | Stephen M R Covey director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 34,550 | Apr 17, 2025 |
| Apr 15, 2025 | Christopher R. Christensen director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 136,491 | Apr 17, 2025 |
| Apr 15, 2025 | Scott E Lamb director | AGrant or award Common Stock | +2,400 | $0.00 | $0 | 46,935 | Apr 17, 2025 |
| Apr 15, 2025 | Gregory K Morris Sr. director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 27,800 | Apr 17, 2025 |
| Apr 15, 2025 | John G. Nackel director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 165,065 | Apr 17, 2025 |
| Apr 15, 2025 | JoAnne Stringfield director | AGrant or award Common Stock | +1,900 | $0.00 | $0 | 30,940 | Apr 17, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Stephen M R Coveydirector
- Kirk Sterling CheneyEVP, GC and Corp Secy
- Christopher R. Christensendirector, chair, officer
- John J GochnourChief Operating Officer
- Brent GuerisoliChief Executive Officer
- Scott E Lambdirector
- Gregory K Morris Sr.director
- John G. Nackeldirector
- Barry M Smithdirector
- Suzanne D. Snappercfo, officer, director
- Jason Paul SteikChief Clinical Officer
- JoAnne Stringfielddirector
- Lynette WalbomChief Financial Officer
Questions about PNTG
Answered from the filings on this page, as of the latest one.
Are insiders buying PNTG?
No. In the last 90 days no insider at Pennant Group, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PNTG on the open market?
Kirk Sterling Cheney (EVP, GC and Corp Secy) sold $21k of PNTG on Jul 28, 2025 and filed the Form 4 on Aug 7, 2025. InsiderTell scored 3 (weak), under a 10b5-1 plan, with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Pennant Group, Inc.?
13 people have filed a Form 4 at Pennant Group, Inc., among them Stephen M R Covey (director), Kirk Sterling Cheney (EVP, GC and Corp Secy), Christopher R. Christensen (director and chair). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.